K8体育-K8体育官方网站-K8体育APP-最新体育赛事资讯、实时赔率分析及在线投注平台K8体育

澳门赌城 体育博彩平台官网 网络赌博平台入口 靠谱的大发彩票 老葡京网址 Skip to main content

March 2024 drug trend report

March 13, 2024

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to learn more.

Brand name drug launches*

Uzedy

  • Indicated for: Treatment of schizophrenia in adults
  • Dosage form: Long-acting injectable administered subcutaneously in the abdomen or upper arm.
  • Status: Available now

For more information on the new treatment option for adults living with schizophrenia, read the Uzedy™ blog post here.

Generic drug launches*

Pradaxa (dabigatran etexilate mesylate)

  • Indicated for: Treatment of nonvalvular partial fibrillation and venous thromboembolism
  • Dosage form: Capsules
  • Status: Available now

Top drug shortages*

Naltrexone

  • Indicated for: Treatment of alcohol and/or opioid use disorder
  • Status: Recovery TBD

Trulicity

  • Indicated for: Treatment of type 2 diabetes
  • Status: Recovery TBD

Paliperidone

  • Indicated for: Treatment of schizophrenia and schizoaffective disorder
  • Status: Recovery TBD

People-first, full-service pharmacy

Stay connected!

For regular updates on drug trends, shortages, and other behavioral health news, subscribe to Genoa’s newsletter and sign up for event and insights notifications. Looking for more information on Genoa and our pharmacy services? Contact us and we’ll be in touch. 

*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.

bwin中国 网络博彩排名买球平台推荐 体育博彩app网址 美狮美高梅 推荐网上赌博大全